Moby Strategic Performance and Operational Drivers. Management attributed solid Q2 performance to broad-based executi ...
14hon MSN
BD forecasts FY 2026 adjusted EPS of $12.52-$12.72 while reaffirming low-single-digit revenue growth
Q2 fiscal 2026 Management view "We delivered a solid second quarter with revenue, adjusted margins and adjusted EPS all ahead of our expectations" (President, CEO & Chairman Thomas Polen), adding, ...
StockStory.org on MSN
BD’s (NYSE:BDX) Q1 CY2026 sales beat estimates
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced in Q1 CY2026, with sales up 5.2% year on year ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that Vitor Roque has been named ...
Marietta, Ga.-based Wellstar Health System is partnering with medtech company Becton Dickinson and Company (BD) to integrate ...
Medical Device Network on MSN
BD and Wellstar partner to improve hospital medication delivery systems
The deployment incorporates AI through the BD Pyxis Pro Dispensing Solution with Analytics in BD Incada.
On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results